India Incorporation- Update I

I am back after a short hiatus, In the beginning of this week there have been lot more events happening in India and United states M&A market, India's own CIPLA is trying for a generic deal with either Pfizer or Takeda Japan , India advantage for both Pfizer and Takeda is that Pfizer's global competitor GSK has already signed deal with Dr Reddy's for 100 generic drug worldwide marketing deal and on the other had Takeda's Japanese market competitor Daichii had sometime back acquired India’s largest generic firm Ranbaxy, Now we have to wait and watch out of Uncle Sam or Japanese Samurai who is actually forming an alliance with CIPLA :)